BJP Try Advances in Psychiatric Treatment Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Semple, D. M.
Right arrow Articles by Johnstone, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Semple, D. M.
Right arrow Articles by Johnstone, E. C.

The British Journal of Psychiatry 175: 63-69 (1999)
© 1999 The Royal College of Psychiatrists

Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users

DM Semple, KP Ebmeier, MF Glabus, RE O'Carroll and EC Johnstone
University Department of Psychiatry, Royal Edinburgh Hospital.

BACKGROUND: The use of MDMA ('ecstasy') is common among young people in Western countries. Animal models of MDMA toxicity suggest a loss of serotonergic neurons, and potentially implicate in the development of significant psychiatric morbidity in humans. AIMS: To test whether long- term use of MDMA can produce abnormalities in cerebral serotonin, but not dopamine, transporter binding measured by single photon emission computed tomography (SPECT). METHOD: Ten male regular ecstasy users and 10 well-matched controls recruited from the same community sources participated in SPECT with the serotonin transporter (SERT) ligand [123I] beta-CIT. Dopamine transporter binding was determined from scans acquired 23 hours after injection of the tracer. RESULTS: Ecstasy users showed a cortical reduction of SERT binding, particularly prominent in primary sensory-motor cortex, with normal dopamine transporter binding in lenticular nuclei. CONCLUSIONS: This cross-sectional association study provides suggestive evidence for specific, at least temporary, serotonergic neurotoxicity of MDMA in humans.


This article has been cited by other articles:


Home page
 J PsychopharmacolHome page
S. de Sola LLopis, M. Miguelez-Pan, J. Pena-Casanova, S. Poudevida, M. Farre, R. Pacifici, P. Bohm, S. Abanades, A. Verdejo Garcia, K. Langohr, et al.
Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study
J Psychopharmacol, July 1, 2008; 22(5): 498 - 510.
[Abstract] [PDF]

Home page
 Arch Gen PsychiatryHome page
T. Schilt, M. M. L. de Win, M. Koeter, G. Jager, D. J. Korf, W. van den Brink, and B. Schmand
Cognition in Novice Ecstasy Users With Minimal Exposure to Other Drugs: A Prospective Cohort Study
Arch Gen Psychiatry, June 1, 2007; 64(6): 728 - 736.
[Abstract] [Full Text] [PDF]

Home page
 J PsychopharmacolHome page
B. B. Quednow, F. Jessen, K.-U. Kuhn, W. Maier, I. Daum, and M. Wagner
Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction
J Psychopharmacol, May 1, 2006; 20(3): 373 - 384.
[Abstract] [PDF]

Home page
 J PsychopharmacolHome page
L. Reneman, T. Schilt, M. M. de Win, J. Booij, B. Schmand, W. v. den Brink, and O. Bakker
Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users
J Psychopharmacol, May 1, 2006; 20(3): 389 - 399.
[Abstract] [PDF]

Home page
 J PsychopharmacolHome page
C. Guillot and D. Greenway
Recreational ecstasy use and depression
J Psychopharmacol, May 1, 2006; 20(3): 411 - 416.
[Abstract] [PDF]

Home page
 J PsychopharmacolHome page
A. C. Parrott and C. A. Marsden
MDMA (3,4-methylenedioxymethamphetamine) or ecstasy: the contemporary human and animal research perspective
J Psychopharmacol, March 1, 2006; 20(2): 143 - 146.
[PDF]

Home page
 J PsychopharmacolHome page
L. Reneman, M. M. L. de Win, W. van den Brink, J. Booij, and G. J. den Heeten
Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects
J Psychopharmacol, March 1, 2006; 20(2): 164 - 175.
[Abstract] [PDF]

Home page
 J PsychopharmacolHome page
N. Easton and C. A. Marsden
Ecstasy: Are animal data consistent between species and can they translate to humans?
J Psychopharmacol, March 1, 2006; 20(2): 194 - 210.
[Abstract] [PDF]

Home page
 J PsychopharmacolHome page
R. Thomasius, P. Zapletalova, K. Petersen, R. Buchert, B. Andresen, L. Wartberg, B. Nebeling, and A. Schmoldt
Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective
J Psychopharmacol, March 1, 2006; 20(2): 211 - 225.
[Abstract] [PDF]

Home page
 J PsychopharmacolHome page
C. T. J. Lamers, A. Bechara, M. Rizzo, and J. G. Ramaekers
Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls
J Psychopharmacol, March 1, 2006; 20(2): 302 - 311.
[Abstract] [PDF]

Home page
 Arch Gen PsychiatryHome page
Y. Sekine, Y. Ouchi, N. Takei, E. Yoshikawa, K. Nakamura, M. Futatsubashi, H. Okada, Y. Minabe, K. Suzuki, Y. Iwata, et al.
Brain Serotonin Transporter Density and Aggression in Abstinent Methamphetamine Abusers
Arch Gen Psychiatry, January 1, 2006; 63(1): 90 - 100.
[Abstract] [Full Text] [PDF]

Home page
 J PsychopharmacolHome page
A. Gamma, D. Brandeis, R. Brandeis, and F. X. Vollenweider
The P3 in 'ecstasy' polydrug users during response inhibition and execution
J Psychopharmacol, September 1, 2005; 19(5): 504 - 512.
[Abstract] [PDF]

Home page
 J PsychopharmacolHome page
A. C. Parrott
Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy
J Psychopharmacol, January 1, 2005; 19(1): 71 - 83.
[Abstract] [PDF]

Home page
 Am. J. PsychiatryHome page
R. Buchert, R. Thomasius, F. Wilke, K. Petersen, B. Nebeling, J. Obrocki, O. Schulze, U. Schmidt, and M. Clausen
A Voxel-Based PET Investigation of the Long-Term Effects of "Ecstasy" Consumption on Brain Serotonin Transporters
Am J Psychiatry, July 1, 2004; 161(7): 1181 - 1189.
[Abstract] [Full Text] [PDF]

Home page
 J PsychopharmacolHome page
S. L. Verheyden, R. Maidment, and H. V. Curran
Quitting Ecstasy: An Investigation of Why People Stop Taking the Drug and Their Subsequent Mental Health
J Psychopharmacol, December 1, 2003; 17(4): 371 - 378.
[Abstract] [PDF]

Home page
 Pharmacol. Rev.Home page
A. R. Green, A. O. Mechan, J. M. Elliott, E. O'Shea, and M. I. Colado
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy")
Pharmacol. Rev., September 1, 2003; 55(3): 463 - 508.
[Abstract] [Full Text] [PDF]

Home page
 Br Med BullHome page
A R Lingford-Hughes, S J C Davies, S McIver, T M Williams, M R C Daglish, and D J Nutt
Addiction: Imaging in clinical neuroscience
Br. Med. Bull., March 1, 2003; 65(1): 209 - 222.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
R. Buchert, R. Thomasius, B. Nebeling, K. Petersen, J. Obrocki, L. Jenicke, F. Wilke, L. Wartberg, P. Zapletalova, and M. Clausen
Long-Term Effects of "Ecstasy" Use on Serotonin Transporters of the Brain Investigated by PET
J. Nucl. Med., March 1, 2003; 44(3): 375 - 384.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
A. LINGFORD-HUGHES and D. NUTT
Neurobiology of addiction and implications for treatment
The British Journal of Psychiatry, February 1, 2003; 182(2): 97 - 100.
[Full Text] [PDF]

Home page
 J. Neuropsychiatry Clin. Neurosi.Home page
R. A. Hurley, L. Reneman, and K. H. Taber
Ecstasy in the Brain: A Model for Neuroimaging
J Neuropsychiatry Clin Neurosci, May 1, 2002; 14(2): 125 - 129.
[Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
L. Reneman, C. B. L. M. Majoie, H. Flick, and G. J. den Heeten
Reduced N-Acetylaspartate Levels in the Frontal Cortex of 3,4-Methylenedioxymethamphetamine (Ecstasy) Users: Preliminary Results
AJNR Am. J. Neuroradiol., February 1, 2002; 23(2): 231 - 237.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
H. Kalant
The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs
Can. Med. Assoc. J., October 1, 2001; 165(7): 917 - 928.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
L. Reneman, J. Lavalaye, B. Schmand, F. A. de Wolff, W. van den Brink, G. J. den Heeten, and J. Booij
Cortical Serotonin Transporter Density and Verbal Memory in Individuals Who Stopped Using 3,4-Methylenedioxymethamphetamine (MDMA or "Ecstasy"): Preliminary Findings
Arch Gen Psychiatry, October 1, 2001; 58(10): 901 - 906.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
U. D. McCann, G. A. Ricaurte, and M. E. Molliver
"Ecstasy" and Serotonin Neurotoxicity: New Findings Raise More Questions
Arch Gen Psychiatry, October 1, 2001; 58(10): 907 - 908.
[Full Text] [PDF]

Home page
 RadiologyHome page
L. Reneman, C. B. L. M. Majoie, J. B. A. Habraken, and G. J. den Heeten
Effects of Ecstasy (MDMA) on the Brain in Abstinent Users: Initial Observations with Diffusion and Perfusion MR Imaging
Radiology, September 1, 2001; 220(3): 611 - 617.
[Abstract] [Full Text] [PDF]

Home page
 J. Neuropsychiatry Clin. Neurosi.Home page
T. Murai, U. Muller, K. Werheid, D. Sorger, M. Reuter, T. Becker, D. Y. von Cramon, and H. Barthel
In Vivo Evidence for Differential Association of Striatal Dopamine and Midbrain Serotonin Systems With Neuropsychiatric Symptoms in Parkinson's Disease
J Neuropsychiatry Clin Neurosci, May 1, 2001; 13(2): 222 - 228.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
A. Heinz, D. W. Jones, K. P. Ebmeier, D. M. Semple, M. F. Glabus, R. E. O'Carroll, and E. C. Johnstone
Serotonin transporters in ecstasy users
The British Journal of Psychiatry, February 1, 2000; 176 (2): 193a - 195a.
[Full Text] [PDF]

Home page
 JWatch PsychiatryHome page
Cognitive and Neurotoxic Effects of 'Ecstasy'
Journal Watch Psychiatry, October 1, 1999; 1999(1001): 9 - 9.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1999 The Royal College of Psychiatrists.